✦ LIBER ✦

Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer

✍ Scribed by M.-S. Yen; C.-M. Juang; C.-R. Lai; G.-C. Chao; H.-T. Ng; C.-C. Yuan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five-Year Survival after Second-Line Cis

✍ Fernando O. Recio; M.Steven Piver; Ronald E. Hempling; Deborah L. Driscoll 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Evaluation of survival after second-line

✍ M. Steven Piver; Fernando O. Recio; Trudy R. Baker; Deborah Driscoll 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

Intraperitoneal cisplatin and paclitaxel

✍ Robert E. Bristow; Antonio Santillan; Ritu Salani; Teresa P. Diaz-Montes; Robert 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Five-year survival for stage IC or stage

✍ M.Steven Piver; John Malfetano; Trudy R. Baker; Ronald E. Hempling 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 323 KB

A decade of experience with cisplatin-ba

✍ D. Gershenson; M.Follen Mitchell; N. Atkinson; E. Silva; J. Kavanagh; M. Morris; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 162 KB

The effect of prolonged cisplatin-based

✍ David M. Gershenson; Michele F. Mitchell; Neely Atkinson; Elvio G. Silva; John J 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 749 KB